OOIR: Observatory of International Research

Papers

(The TQCC of European Respiratory Review is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Reply to: “Nicotine or tobacco abstinence?”	281
European Respiratory Review, list of peer reviewers 2022	190
Ventilation/perfusion mismatch is not the sole reason for hypoxaemia in early stage COVID-19 patients	141
European Respiratory Review, list of peer reviewers 2023	136
Exacerbations of bronchiectasis	128
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis	121
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension	114
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis	114
Health disparities and associated social determinants of health in interstitial lung disease: a narrative review	112
Cough monitoring systems in adults with chronic respiratory diseases: a systematic review	99
Live teleultrasound for evaluation of the chest: a systematic review	94
The role of telemonitoring in patients on home mechanical ventilation	84
ERS/EAACI statement on adherence to international adult asthma guidelines	81
Multiple breath washout and oscillometry after allogenic HSCT: a scoping review	81
The re-emerging role of linoleic acid in paediatric asthma	80
Treatable traits in asthma during pregnancy: a call for a shift towards a precision-based management approach	78
Global respiratory health priorities at the beginning of the 21st century	73
Lung stem cells and respiratory epithelial chimerism in transplantation	72
Advance care planning in patients with respiratory failure	69
Quality of life in patients with chronic respiratory failure on home mechanical ventilation	68
Air pollution as an early determinant of COPD	66
Inhaled corticosteroids for the treatment of COVID-19	66
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension	64
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell	64
Epidemiology of severe asthma in children: a systematic review and meta-analysis	64

Diaphragm excursion and diaphragm thickening fraction: commonality and conflict	62
The ageing of people living with cystic fibrosis: what to expect now?	62
Integrating asthma care guidelines into primary care electronic medical records: a review focused on Canadian knowledge translation tools	60
Sarcopenia in interstitial lung disease	60
Sex and gender in interstitial lung diseases	59
Characteristics of scores used for quantitative lung ultrasound in neonates: a systematic review	59
Phenotype overlap in the natural history of asthma	56
Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis	56
A pulmonologist's guide to perform and analyse cross-species single lung cell transcriptomics	55
Smoking cessation and vaccination	54
Recreating chronic respiratory infectionsin vitrousing physiologically relevant models	53
Prognostic biomarkers for the development of progressive pulmonary fibrosis in hypersensitivity pneumonitis: a systematic review	52
Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review	51
Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis	48
Methods to assess COPD medications adherence in healthcare databases: a systematic review	46
Harmonising cellular conversations: decoding the vital roles of extracellular vesicles in respiratory system intercellular communications	44
Sex and gender in respiratory physiology	43
Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis	43
Pathophysiology and genomics of bronchiectasis	43
Nonpharmacological interventions in COPD	43
Mitogen-activated protein kinase-guided drug discovery for post-viral and related types of lung disease	42
Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome	42
REM sleep obstructive sleep apnoea	42
Pro: Clinical remission in asthma – implications for asthma management	41
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future	41
Investigating the prognostic value of digital mobility outcomes in patients with chronic obstructive pulmonary disease: a systematic literature review and meta-analysis	41
Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an indivi	40
Sex and gender in pulmonary arterial hypertension	40
Extreme weather and asthma: a systematic review and meta-analysis	39
Advanced imaging techniques and artificial intelligence in pleural diseases: a narrative review	38
Airway ciliated cells in adult lung homeostasis and COPD	38
Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis	37
Adherence-enhancing interventions for pharmacological and oxygen therapy in patients with COPD: a systematic review and component network meta-analyses	37
Interplay between respiratory viruses and cilia in the airways	37
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection	37
The persistent inflammation in COPD: is autoimmunity the core mechanism?	36
Bronchiolar disorders in systemic autoimmune rheumatic diseases	36
Extrapulmonary effects of lung volume reduction in severe emphysema: a systematic review	36
COVID-19 and tuberculosis: the double whammy of respiratory pathogens	35
Sex and gender in lung health and disease: more than just Xs and Ys	35
Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours	34
Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis	34
The oesophageal balloon for respiratory monitoring in ventilated patients: updated clinical review and practical aspects	34
Preclinical models of maternal asthma and progeny outcomes: a scoping review	34
Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristics	34
“Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms.” S. Malenfant, M. Lebret, É. Breton-Gagnon,et al.Eur Respir Rev	33
Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review	32
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations	32
Does pulmonary rehabilitation address treatable traits? A systematic review	32
Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?	32

New trends in pulmonary hypertension	31
Association between second-hand smoke exposure and lung cancer risk in never-smokers: a systematic review and meta-analysis	31
Parasitic lung diseases	31
Positive airway pressure therapy for post-stroke sleep disordered breathing: a systematic review, meta-analysis and meta-regression	31
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD	30
Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD	29
Molecular monitoring of lung allograft health: is it ready for routine clinical use?	29
The epithelial era of asthma research: knowledge gaps and future direction for patient care	28
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis	28
Recycling plastic: diagnosis and management of plastic bronchitis among adults	27
The association between alcohol consumption and pulmonary function: a scoping review	27
Bronchiectasis in Asia: a review of current status and challenges	27
Predictors of sleep disordered breathing in children with Down syndrome: a systematic review and meta-analysis	27
Breathing techniques to reduce symptoms in people with serious respiratory illness: a systematic review	27
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials	27
Impact of climate change on paediatric respiratory health: pollutants and aeroallergens	27
Fixed-intensity exercise tests to measure exertional dyspnoea in chronic heart and lung populations: a systematic review	26
Association between air pollution and allergic upper respiratory diseases: a meta-analysis	26
Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis	25
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review	25
A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?	25
From treatable traits to GETomics in airway disease: moving towards clinical practice	25
Evidence-based management of symptoms in serious respiratory illness: what is in our toolbox?	25
Nitrogen single and multiple breath washout test and lung imaging to detect treatment-related pulmonary toxicity in paediatric cancer patients and survivors: a systematic review	24
Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis	24
“Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD”. Ariel A. Calderon, Colin Dimond, David F. Choy, Rajita Pappu, Michele A. Grimb	24
Digital twins for chronic lung diseases	24
Hypoxaemia in the early stage of COVID-19: prevalence of physical or biochemical factors?	24
Global birth prevalence of Robin sequence in live-born infants: a systematic review and meta-analysis	23
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis	23
Biologics in severe asthma: the role of real-world evidence from registries	23
Managing an ageing cystic fibrosis population: challenges and priorities	23
Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis	23
Stem cell therapy in pulmonary hypertension: current practice and future opportunities	23
Supplemental oxygen for symptomatic relief in people with serious respiratory illness: a systematic review and meta-analysis	23
The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group	22
Nebulised granulocyte–macrophage colony-stimulating factor (GM-CSF) in autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis	22
Determining the minimum important differences for field walking tests in adults with long–term conditions: a systematic review and meta-analysis	22
Cytokine-targeted therapies for asthma and COPD	22
Gait differences between COPD and healthy controls: systematic review and meta-analysis	22
Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives	22